rs1899951

This is a intron variant variant in the PPARG gene.

GWAS Catalog Trait Associations (10)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

type 2 diabetes mellitus

Allele T
OR 0.11
p 2.0e-24
N 659,316
Large GWAS
multi-ancestry

calcium measurement

Sakaue S et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nature Genetics 53(10):1415-1424 (2021)
Allele T
OR 0.03
p 3.0e-21
N 399,133
Large GWAS
multi-ancestry

valine measurement

Zoodsma M et al. A genetic map of human metabolism across the allele frequency spectrum. Nature Genetics 57(10):2445-2455 (2025)
Allele T
OR 0.03
p 3.0e-20
N 450,015
Large GWAS
multi-ancestry

urate measurement

Cho C et al. Large-scale cross-ancestry genome-wide meta-analysis of serum urate. Nature Communications 15(1):3441 (2024)
Allele T
OR 0.02
p 4.0e-9
N 677,373
Meta-analysisLarge GWAS
European

body mass index

Allele T
OR 0.02
p 6.0e-9
N 158,284
Large GWAS
multi-ancestry
Sidorenko J et al. Genetic architecture reconciles linkage and association studies of complex traits. Nature Genetics 56(11):2352-2360 (2024)
Allele T
OR 0.02
p 7.0e-9
N 650,000
Large GWAS
European

About PPARG

This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008]

View all PPARG variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…